Detalles de la búsqueda
1.
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.
J Hepatol
; 74(4): 801-810, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33220331
2.
A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study.
AIDS Res Ther
; 17(1): 61, 2020 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054784
3.
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
J Antimicrob Chemother
; 74(9): 2732-2741, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31173639
4.
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
BMC Public Health
; 19(1): 1291, 2019 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31615542
5.
Entheseal involvement in asymptomatic human immunodeficiency virus infected patients: preliminary results of a clinical and ultrasonographic study.
Clin Exp Rheumatol
; 36(5): 862-870, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846159
6.
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
BMC Infect Dis
; 18(1): 10, 2018 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304747
7.
Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study.
BMC Infect Dis
; 17(1): 193, 2017 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264665
8.
Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
BMC Infect Dis
; 17(1): 551, 2017 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28793863
9.
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.
BMC Infect Dis
; 17(1): 212, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28298195
10.
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians.
New Microbiol
; 40(2): 139-142, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28072892
11.
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
J Antimicrob Chemother
; 71(12): 3519-3527, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27543658
12.
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
BMC Public Health
; 16(1): 878, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557878
13.
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study).
New Microbiol
; 39(4): 290-294, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27551725
14.
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study.
New Microbiol
; 39(4): 241-246, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27727402
15.
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
Retrovirology
; 12: 33, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924841
16.
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
Retrovirology
; 11: 49, 2014 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961156
17.
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
J Antimicrob Chemother
; 69(3): 735-41, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24155059
18.
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
J Antimicrob Chemother
; 68(1): 193-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22984206
19.
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.
Ther Drug Monit
; 35(6): 785-90, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24061444
20.
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.
BMC Infect Dis
; 13: 414, 2013 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24004495